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Although the importance of viral fusion peptides in virus-cell membrane fusion is established, little is known about how they func-
tion. We report the effects of wild-type (WT) hemagglutinin (HA) fusion peptide and its G1S, G1V, and W14A mutants on the
kinetics of poly(ethylene glycol)(PEG)-mediated fusion of small unilamellar vesicles composed of dioleoylphosphatidylcholine,
dioleoylphosphatidylethanolamine, sphingomyelin, and cholesterol (molar ratio of 35:30:15:20). Time courses of lipid mixing,
content mixing, and content leakage were obtained using fluorescence assays at multiple temperatures and analyzed globally
using either a two-step or three-step sequential ensemble model of the fusion process to obtain the rate constant and activation
thermodynamics of each step. We also monitored the influence of peptides on bilayer interfacial order, acyl chain order, bilayer
free volume, and water penetration. All these data were considered in terms of a recently published mechanistic model for the
thermodynamic transition states for each step of the fusion process. We propose that WT peptide catalyzes Step 1 by occupying
bilayer regions vacated by acyl chains that protrude into interbilayer space to form the Step 1 transition state. It also uniquely
contributes a positive intrinsic curvature to hemi-fused leaflets to eliminate Step 2 and catalyzes Step 3 by destabilizing the high-
ly stressed edges of the hemi-fused microstructures that dominate the ensemble of the intermediate state directly preceding
fusion pore formation. Similar arguments explain the catalytic and inhibitory properties of the mutant peptides and support
the hypothesis that the membrane-contacting fusion peptide of HA fusion protein is key to its catalytic activity.INTRODUCTIONMembrane fusion is vital to the life of eukaryotic cells.
Many processes such as cellular trafficking and compart-
mentalization, import of nutrients and export of waste,
cellular communication, sexual reproduction, and cell divi-
sion are all dependent on this basic process. It is also an
essential step for the entry of viruses into host cells. There
is now fairly wide agreement that fusion, whether viral-pro-
tein-mediated (1), exocytotic-protein mediated (2), or in
model membranes (3,4), proceeds through multiple steps
and, at different stages of the process, involves small tran-
sient, or large stable pores (1,4,5). Since fusion between
membranes with compositions that mimic mammalian
membranes (6) is not spontaneous, it is likely that fusion
proteins both provide free energy to drive membranes into
close contact and catalyze the lipid rearrangements required
in biomembrane fusion (7). Our hypothesis has been that
membrane-contacting regions of fusion proteins are the
key catalytic units of these fusion machines.
Awell-studied fusion protein (8–11) is the hemagglutinin
(HA) protein of influenza virus. Influenza virus HA has a
short N-terminal region termed ‘‘fusion peptide’’ that hasSubmitted January 4, 2013, and accepted for publication October 9, 2013.
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0006-3495/13/12/2495/12 $2.00been shown by mutational analysis to be critical for fusion
(12). Although HA fusion peptide alone does not induce
pore formation, it does induce aggregation and membrane
rupture at high peptide to lipid ratios (>1:200), and it
does promote pore formation in PEG-induced model mem-
brane fusion at lower P/L ratios (13–15). Mutants of the HA
fusion protein with reduced physiological or ex-vivo mem-
brane lytic function (G13L, G1E) have fusion peptides that
do not promote pore formation, although the mechanistic
basis for this remains unknown (15). Structures of N-termi-
nal peptides from three mutants (G1S, G1V, and W14A) of
the X31 strain have been proposed based on NMR and spin
labeling data (16–18). Phenotypes of these three mutant
viruses are also well established. This wealth of informa-
tion provides an excellent opportunity to examine how viral
fusion peptides catalyze fusion.
Several proposals exist for how fusion proteins (specif-
ically fusion peptide regions) might catalyze fusion
(15,19–22). Most of these relate to a mechanistic model of
fusion as a multiintermediate process (‘‘modified stalk’’
hypothesis) as developed for planar membranes by Siegel
in terms of material properties of mesomorphic lipid phases
(23) and extended by us to highly curved membranes (24).
These models are not molecular in detail, although the
two most critical events in the fusion process (initial inter-
mediate formation and pore formation) are transitions
between stable or semistable lipid structures of different
topologies and thus must involve dramatic rearrangementshttp://dx.doi.org/10.1016/j.bpj.2013.10.010
2496 Chakraborty et al.of water and lipids that require molecular descriptions (24).
The principal difficulties inherent in studying these transi-
tions are that they are very short lived (most estimates indi-
cate pores open in ~1 to 50 ms) and likely involve only a few
lipids in a very small region of interbilayer contact (prob-
ably( 2 to 4 nm on edge) (25–27). Methods to experimen-
tally detect distinct molecular rearrangements on this time
and length scale do not exist. Nonetheless, recent single-
event measurements demonstrate that the multiintermediate
model clearly applies to single fusion events (2,28). Unfor-
tunately, even these elegant single-event measurements lack
the spatial and time resolution to report microstructural or
molecular details of fusion events. Even if it were possible
to resolve such structural changes on a relevant time and
length scale, membranes do not move in concert through
intermediate states, so statistical methods must still be
used to interpret even single-event observations.
Our approach to these challenges has been to use an
ensemble kinetic model that is consistent with the multiin-
termediate structural hypothesis (29) and that is uniquely
able to provide activation thermodynamics for each step
of the multistep fusion process (30). The multiintermediate
nature of fusion is widely supported experimentally, and our
ensemble kinetic approach has already produced reasonable
hypotheses for the nature of microstructures contributing
to the initial and final steps of the fusion process, which
are consistent with independently performed molecular
dynamics (MD) simulations (30). In this paper, we combine
activation thermodynamics with measured effects of pep-
tides on membrane structure to propose hypotheses for
how WT or mutant HA fusion peptides could alter these
microstructural events and thereby catalyze or inhibit fusion
of highly curved membranes as triggered by PEG.EXPERIMENTAL PROCEDURES
We described the methods that are quite routine in our lab for preparing
small unilamellar vesicles (SUVs), and for measuring mixing of contents
and lipids between them and leakage of contents from them using fluores-
cence assays in the Supporting Material. In addition, we monitor peptide
structure by CD (Circular Dichroism) spectroscopy, peptide binding to
membranes by intrinsic fluorescence, and the influence of peptides on
SUV structure using a variety of fluorescent probes, as also detailed in
the Supporting Material.Preparation of HA peptides
The native and mutants of X-31 HA peptides were chemically synthesized
by standard solid phase method using Fmoc chemistry and purified by the
peptide synthesis laboratory at the University of North Carolina-Chapel
Hill. The sequences of the peptides are GLFGAIAGFIENGWEGMIDG
(X-31 HA, native, WT), SLFGAIAGFIENGWEGMIDG (G1S), VLFG
AIAGFIENGWEGMIDG (G1V) and GLFGAIAGFIENGAEGMIDG
(W14A). Detailed descriptions of the synthesis and purification of WT pep-
tides are given in previous publication (14). Stock peptide solutions were
prepared in DMSO (Dimethyl sulfoxide) solvent, and small aliquots of these
solutions were added to vesicle suspensions. DMSO was always less than
0.1% of the buffer volume for fusion and membrane structure experimentsBiophysical Journal 105(11) 2495–2506and 0.8% for peptide binding experiments. Control experiments in a
peptide-free system showed that 0.8 volume % of DMSO had no effect on
the structural properties of the bilayers or on the kinetics of fusion.PEG-triggered SUV fusion
PEG treatment is a widely accepted method for accomplishing close contact
of membranes and is thus used to mediate fusion of model membranes (31).
Since membrane curvature is known to promote fusion in vitro (32) and is
thought to do so in vivo (7), we use highly curved model membranes
(SUVs) for our fusion studies. These are routinely prepared as described in
the Supporting Material. PEG aggregates SUVs at rates ~10-fold higher
than the rate of any fusion event we have resolved at the concentrations of
PEG we use. This results in an initial state of close contact between mem-
branes referred to as ‘‘A’’ (see diagram in Supporting Material) from which
ourmeasurements proceed. This avoids the complication of vesicle diffusion
and ‘‘docking’’ in our data analysis. For these reasons, PEG-mediated model
membrane fusion of SUVs is an excellent mimic of biomembrane fusion (3).Recording and analyzing the fusion time courses
and calculation of activation thermodynamics
In our ensemble kinetic model, a thermodynamic state with aggregated ves-
icles in close contact (A) transforms to an initial intermediate state (I1) at
rate k1; I1 then transforms to a second intermediate state (I2) with rate k2;
and I2 on to a fusion pore (FP) state with rate k3. These are thermodynamic
states that are associated with average probabilities that lipids (b’s) and
contents (a’s) mix as well as average rates of leakage (l’s). The details
of how we analyze kinetic data and obtain activation thermodynamics are
given in the Supporting Material and in previous publications (29,30).
Briefly, global analysis of time courses of three observables (content
mixing, content leakage, lipid mixing) allows us to estimate the three (or
two) rate constants for interstate conversion, as well the above mentioned
probabilities associated with the different thermodynamic states assumed
by the model. A more detailed discussion of these probabilities and their
meaning along with a diagram of the ensemble kinetic model is given in
the Supporting Material. As well as proposing reasonable models for the
microstructural nature of transition states between intermediate states in
the fusion process (30), we have successfully utilized these methods to
analyze ensemble kinetic data for the effects of peptides (15) and cal-
cium/negatively charged lipids (33) on SUV fusion.RESULTS
Effect of HA fusion peptide and its mutants on
kinetics of PEG-mediated SUV fusion
A low concentration of PEG (5% w/w) had no influence
on the Trp fluorescence intensity, membrane binding of
the peptide, or depth of peptide membrane penetration
(14,15). These three independent measurements indicate
that the low concentrations of PEG used in our experiments
do not affect the peptide-membrane complex or the physical
state of the peptide in solution.
Time courses of lipid mixing (LM), content mixing (CM),
and leakage (L) were recorded at five different temperatures
(26C, 30C, 34C, 38C, and 43C) for DOPC/DOPE/SM/
CH SUVs in absence and in presence of peptide (L/P ¼
200), with fusion induced by PEG. Fig. 1 shows the time
courses of LM, CM, and L for control vesicles alone and
in the presence of wild-type (WT) and mutant fusion
FIGURE 1 Effect of HA WT fusion peptide (green), G1S (red), G1V
(cyan), and W14A (pink) mutants compared with absence of peptide
(dark gray), i.e., control for kinetics of lipid mixing, contents mixing and
leakage in PC/PE/SM/CH (35/30/15/20 mol%) SUVs, for fusion induced
by 5wt% PEG at 30C. Results (fraction of fluorescence intensity change)
are shown for a lipid to peptide ratio 200:1. Measurements were carried out
in 10 mMMES, 100 mM NaCl, 1mM CaCl2, and 1 mM EDTA, pH 5.0 at a
total lipid concentration of 0.2 mM. The smooth curves through the data
represent either four-state (for control, G1S and W14A) or three-state
(for WT HA fusion peptide and G1V) sequential model global fit. To see
this figure in color, go online.
Effects of HA Fusion Peptides on Bilayer Structure, Fusion Kinetics, and Activation Thermodynamics 2497peptides at 30C. These data were fitted globally for each
peptide to either a three-step or two-step (four-state or
three-state) sequential ensemble model (15,29,30,33) to
obtain the rate constants for each step and probabilities of
lipid mixing (b’s) and content mixing (a’s) in each state,
as listed in Table 1. Data for WT peptide at 26C were
slightly better described by the four-state model (as reported
in Table 1) than by the three-state model (not shown), but
either model was judged to be appropriate. Above 26C,
description of data obtained with WT peptide requiredonly a three-state model. We interpret this to mean that
either the I1 or I2 state was nearly or completely invisible
in the presence of WT peptide. Black lines through the
data in Fig. 1 illustrate the ability of a three-state model to
account for the data.
The four peptides produced very different effects on PEG-
mediated fusion (Table 1). All the peptides increased k1; the
WT peptide did not significantly alter the fraction of lipid
mixing (fLM), although G1S, G1V, and W14A all decreased
fLM slightly. Although the WT peptide increased the extent
of content mixing (fCM), all mutant peptides decreased fCM
significantly. As noted, either the I1 or I2 state was not
discernible in the presence ofWT peptide at 30C and above,
so content mixing occurred in intermediate state (I) with a
probability a and in the FP state with probability (1-a). A
similar statement can be made about the probability of lipid
mixing (b). G1V blocked formation of the FP state (k3z 0),
i.e., blocked fusion; it also greatly increased leakage and trig-
gered a high probability of content mixing early in the fusion
process (a1 ¼ 60%). W14A, similar to G1V, also dramati-
cally enhanced the rate of leakage (12- to 20-fold). Although
G1S andW14A did not block FP state formation completely,
both significantly reduced k3. G1S inhibited content mixing
at I1 (i.e., reduced a1 in favor of a3). W14A did not signifi-
cantly redistribute the mixing of contents relative to the
control. To summarize, the mutant peptides, similar to the
WT peptide, increased the rate but not extent (b1*fLM) of I1
(‘‘stalk’’ (34)) formation, but all three inhibited in some
way pore formation and content mixing. These behaviors
are consistent with the hemi-fusion phenotype reported for
G1S and W14A mutants in HA-expressed-cell– and red-
blood-cell–based assays (17,18). G1Vmutant inhibited lipid
mixing and blocked content mixing (35) in HA-expressed-
cell–based assay, again consistent with our observations
with model membranes. Only the WT peptide increased the
rate of both steps as well as the extent of fusion (fCM).Binding of HA peptides to PC/PE/SM/CH (35/30/
15/20) SUV
Weused intrinsic tryptophan fluorescence tomonitor binding
of HA WT and mutant peptides to PC/PE/SM/CH mem-
branes (13,14). As W14A lacks a tryptophan, we measured
the binding of W14A to PC/PE/SM/CH membrane as
described in Methods (Fig. S1in the Supporting Material).
Experiments were performed at two different concentrations
of the peptide and data were fitted globally to a standard sur-
face-binding model (36). The binding parameters (Kd and N
[stoichiometry]) for all four peptides are shown in Table S2.
These data show that all peptides were more than ~95%
bound tomembranes under the conditions of our experiments
(20 to 6 mM binding sites, 1 mM peptide). We also collected
CD-spectra of the WT and mutant peptides associated
with POPC (1-palmitoyl-2-oleoyl-sn-3-phosphocholine) and
POPC/CH membranes. The corrected spectra (37) wereBiophysical Journal 105(11) 2495–2506
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2498 Chakraborty et al.analyzed (method mentioned in the Supporting Material)
using Dichroweb (London, United Kingdom) (38,39).
Secondary structures of the WT and mutant peptides on
membranes (Table S1 and Fig. S2) generally supported
with proposed structures of peptides attached to a solubi-
lizing ‘‘host peptide’’ and incorporated into micelles
(16–18), allowing us to adopt these host-peptide models as
a starting point for interpreting our data.Effect of wild-type HA fusion peptide and its
mutants on the activation thermodynamics of
PEG-mediated SUV fusion
We calculated the activation free energy for the transition
states for all steps in the fusion process as described in the
Supporting Material. The activation free energy refers to
the difference in free energy between initial states (A, I1,
I2) and the transition states (TS1, TS2, TS3) for formation
of I1, I2, or FP, respectively. Fig. S3 presents a hypothetical
reaction diagram illustrating these. Fig. 2 A shows the
temperature-dependence of DG1 (activation free energy for
Step 1) for the control vesicles (no peptide). Activation
thermodynamics for control system have been discussed in
detail elsewhere (30), but they are reproduced here for refer-
ence. The inset to this figure shows the change in DG1
ðDDG1 ¼ DG1;pep  DG1;controlÞ caused by WT and mutant
peptides. DG1 was a nonlinear function of the reciprocal of
temperature (not shown) in the presence or absence of pep-
tides, meaning it did not follow the simple Arrhenius equa-
tion (constant Van’t Hoff enthalpy) under the conditions
examined. Fig. 2, B and C show similar representations of
the activation free energies for Step 2 (conversion of I1 to
I2) and Step 3 (formation of the FP) for control vesicles.
The activation entropies (DSi ) and enthalpies DH

i were
calculated and plotted in Fig. 3, A, C, and E for Steps 1, 2,
and 3, respectively as described in the Supporting Material.
Fig. 3, B, D, and F present calculated TDDSi and DDH

i
for the WT and the three mutant peptides. The four peptides
all altered the activation thermodynamics differently. The
kinetic parameters obtained in the presence of WT and
mutant peptides are summarized in Table 1. We interpret
these differences along with different effects of peptides on
bilayer structure and proposed peptide structures (16,17) in
the Discussion and Supporting Material in terms of how
theses peptides might alter the microstructures associated
with initial states (A, I1, and I2) or transition states (TS1,
TS2, and TS3) for the three steps of the fusion process (30).Effects of HA fusion peptides on bilayer
properties
We examined the effects of WT and mutant fusion peptides
on bilayer properties of SUVs using C6NBDPC, DPH, and
TMA-DPH, which probe three different bilayer regions
and properties. Externally added C6NBDPC partitions
FIGURE 2 Effect of WT fusion peptide and its mutants on the activation
energy barrier for different steps of membrane fusion process. The activa-
tion free energy for the formation of (A) I1 state ðDG1Þ, (B) I2 state ðDG2Þ,
and (C) pore formation ðDG3Þ is plotted versus temperature for control ves-
icles. Insets show effect of WT fusion peptide (square), G1S (up triangle),
G1V (circle), and W14A (down triangle) mutants on the activation free
energies of the control displayed in each frame. To see this figure in color,
go online.
Effects of HA Fusion Peptides on Bilayer Structure, Fusion Kinetics, and Activation Thermodynamics 2499between micelles and membranes; its fluorescence lifetime
having contributions from the probe in these two environ-
ments, from which one may obtain the partition coefficient
between these two phases (XC6NBDPC), which offers a mea-
sure of free volume within membrane outer leaflets (5).
Fig. 4 A shows that all peptides decreased the mole fraction
of C6NBDPC in the membrane over nearly the entire tem-
perature range, reflective of a decrease in free volume
upon addition of peptide, although the average DXC6NBDPCover the entire temperature range for WT peptide was
considerably more negative than for any mutant peptide
(Fig. 4 A). Because of its polarity, the NBD moiety in C6
NBDPC locates in the upper region of the bilayer near the
interface (40). We conclude that WT generally filled more
upper bilayer space than mutant peptides. In addition,
only WT peptide increased the lifetime of C6NBDPC
(Fig. 4 B). The lifetime of membrane-associated C6NBDPC
provides a measure of thermal motion and polarity (likely
because of water penetration) in the neighborhood of the
NBD probe, so an increase in lifetime must reflect either a
decrease in water penetration to this region or partitioning
of the polar NBD moiety further into the membrane (5).
TMA-DPH reports the acyl chain ordering near the interface
of the bilayer, whereas DPH reports an order parameter for
the interior hydrophobic region of the bilayer. We found
that only WT peptide increased DPH anisotropy at all
temperature, whereas mutants did so only at low tempera-
ture (Fig. 4 C). TMA-DPH anisotropy increased at high
and low temperatures in the presence of WT but remained
unchanged at 308K; it increased at all temperatures for
G1S peptide. G1V decreased TMA-DPH anisotropy and
thus decreased interfacial order at all temperatures;
whereas W14A had different effects at low and high temper-
atures (Fig. 4 D). In summary, WT peptide was notable
compared with all the mutants in its ability to increase
DPH anisotropy (Fig. 4 C) and increase C6NBDPC lifetime.
It also limited C6NBDPC partitioning into the bilayer as
well as or better than all mutant peptides except G1S
at 295K.Comparison of HA fusion peptide and 3 mol%
hexadecane effects on PEG-mediated SUV fusion
The effects of 3 mol% hexadecane on PEG-mediated fusion
of control vesicles have been described previously (30), and
the results are summarized here for comparison with results
obtained with fusion peptide plus hexadecane (Table S4).
Hexadecane increased k1 by ~29% at 30
C (Table S4,
Fig. 5). Subsequent addition of WT fusion peptide increased
it by an additional 16%, but to a value that was still less than
the effect of WT fusion peptide alone (65%; Tables 1
and S4). The ability of hexadecane to promote I1 formation
also increased less rapidly with temperature than did that
of WT peptide, and hexadecane increasingly inhibited the
ability of WT peptide to promote Step 1 with increasing
temperature (Fig. 5 A), suggesting differences in the mech-
anisms of catalysis by these agents at high temperatures.
However, the activation thermodynamics associated with
addition of WT peptide (Fig. 3 B) as well as with addition
of hexadecane (Fig. 5 B) or with the presence of both
indicated enthalpic catalysis by both agents and their com-
bination at low temperatures ðDDH1<TDDS1<0Þ, suggest-
ing possible similarities in catalytic mechanism at low
temperature.Biophysical Journal 105(11) 2495–2506
FIGURE 3 TDS1 and DH

1 for the control vesi-
cles (in absence of peptide) are plotted against tem-
perature for the formation of (A) I1 state, (C) I2
state, and (E) FP state. The temperature depen-
dence of the change in TDS1 (TDDS

1) and DH

1
(DDH1) induced by the presence ofWTand mutant
fusion peptides. TDDSi (solid line) and DDH

i
(dotted line) are plotted for (B) formation of I1
state, (D) formation of I2 state, and (F) pore forma-
tion for WT fusion peptide (green), G1S (red),
G1V (cyan), and W14A (pink) mutants. To see
this figure in color, go online.
2500 Chakraborty et al.Perhaps the most notable effect of hexadecane was to
restore a second intermediate in the presence of WT peptide
and to restore Step 3 (FP formation) in the presence of G1V
mutant with a rate comparable with the effect of hexadecane
alone (Tables 1 and S4). Similarly, G1S and W14A peptides
severely inhibited FP formation (Table 1), and hexadecane
reduced this inhibition (see Dki/ki values in Table S4). OfBiophysical Journal 105(11) 2495–2506the four peptides, only WT increased k3, and hexadecane
reversed this effect (see Dki/ki in Table S4). Since hexade-
cane is known to fill interstice space in nonlamellar struc-
tures, we use the different influences of hexadecane on
WTand mutant peptide effects on Step 3 to suggest different
mechanisms (see Discussion) by which these two classes of
peptides alter Step 3.FIGURE 4 Effect of WT fusion peptide and its
mutants on the temperature dependence of (A)
change in the mole fractions of C6NBD-PC in
membranes exposed to different peptides; (B)
changes in fluorescent lifetime of C6NBD-PC;
(C) DPH anisotropy; and (D) TMA-DPH anisot-
ropy in membranes exposed to different peptides.
Peptide-exposed vesicles are compared with con-
trol vesicles in all cases: WT fusion peptide
(open square); G1S (open up triangle); G1V
(open circle); and W14A (open down triangle)
mutants. Measurements were carried out in
10 mM MES, 100 mM NaCl, 1 mM CaCl2, and
1 mM EDTA, pH 5.0 at a total lipid concentration
of 0.2 mM and lipid/peptide ratio of 200:1 as a
function of temperature.
FIGURE 5 Temperature dependence the free en-
ergy barrier for formation of (A) I1 state (DG

1), (B)
I2 state (DG

2), and (C) pore formation (DG

3) for
control vesicles (open circles), vesicles in the pres-
ence of WT HA fusion peptide (open square), ves-
icles containing 3 mol% hexadecane (solid circle),
and vesicles containing 3 mol% hexadecane in
presence of WT HA fusion peptide (solid square).
(D–F) show TDDSi (solid lines) and DDH

i (dotted
lines) for the formation of I1, I2, and FP state for
hexadecane containing and hexadecane plus WT
peptide vesicles. Measurements were carried out
in 10 mM MES, 100 mM NaCl, 1mM CaCl2, and
1 mM EDTA, pH 5.0 at a total lipid concentration
was 0.2 mM. The lipid/peptide ratio was 200. To
see this figure in color, go online.
Effects of HA Fusion Peptides on Bilayer Structure, Fusion Kinetics, and Activation Thermodynamics 2501Aside from their effects on rates, both hexadecane and the
peptides alter the extent of content mixing and in what inter-
mediate state it occurs, with the effect of hexadecane being
considerably greater than that of peptides (Tables 1 and S4).
Hexadecane significantly increased the extent of content
mixing compared with the control, and the increase was
mainly because of transient pores in states I1 and I2 (i.e.,
a3 decreased in favor of a1 and a2, Table S4). Since WT
peptide eliminated one intermediate state, content mixing
in this state moved to the final pore state (Table 1, 30C
results). Hexadecane-containing vesicles treated with WT
peptide reduced the extent of content mixing to roughly
that seen with WT peptide alone, and restored a significant
fraction of content mixing to an intermediate state from the
final pore state (Tables 1 and S4). We discuss this behavior
when we address possible mechanisms of action of WT pep-
tide on fusion. None of the peptides and hexadecane signif-
icantly altered the extent of lipid mixing.DISCUSSION
We set out to provide evidence for our overriding hypothesis
that membrane-contacting regions of fusion proteins cata-
lyze fusion events. We use an ensemble kinetic analysis
that can establish both kinetics and activation thermody-
namics of individual steps of the fusion process and show
that this analysis is consistent with dwell-time distributionsobtained from single-event measurements (28). Knowledge
of bilayer structure along with a previously published
description of fusion intermediate geometry (24) allow us
to propose interpretations of activation thermodynamics.
Along with this information, measurements of the influence
of WT HA fusion peptide and three nonfusogenic mutants
on bilayer structure provide evidence for several unique
hypotheses:
1. The average or ensemble structures of these peptides
vary with temperature, helping to account for their
observed temperature-dependent effects on kinetics and
activation thermodynamics of fusion steps.
2. WT HA fusion peptide promotes initial intermediate
formation because of its ability to stabilize acyl chain
protrusions in transition state microstructures.
3. The unique ability of WT fusion peptide to impart
intrinsic positive curvature to exposed leaflets of hemi-
fused intermediates explains its ability to eliminate one
step of the fusion process and catalyze fusion pore
formation.
4. Although the catalytic or inhibitory influences of mutant
HA fusion peptides were all peptide specific, these
generally catalyze initial intermediate formation by en-
thalpically destabilizing the initial aggregated state and
also entropically stabilizing intermediate transition states
because of the peptides’ temperature-dependent micro-
structural ensembles. Their abilities to impart a negativeBiophysical Journal 105(11) 2495–2506
2502 Chakraborty et al.intrinsic curvature to exposed leaflets and to stabilize
interstice space generally account for their inhibitory
influences on pore formation.Peptide structure and bilayer properties
The structural model of the 20-residue WT peptide linked to
a polar ‘‘host peptide’’ suggests that it adopts an inverted
V-shaped conformation in micelles and lipid bilayers with
two helices joined by a ‘‘flexible loop’’ involving Glu11,
Asn12, and Gly13 that form a ‘‘kink’’ with an angle of
105 (16). The C-terminal amphipathic helix (residues 16
to 20) occupies the membrane interface, whereas the N-ter-
minal helix (residues 1 to 10) embeds in the hydrophobic
interior of the bilayer to form an ‘‘inverted V’’ (18). A
more recent NMR-based structure of a 23-residue HA fusion
peptide proposes an amphipathic helical hairpin structure
that lies at a micelle surface (41). These authors recently pro-
posed that the 23-residue peptide visits several conforma-
tions (hairpin, L-shaped, inverted V) on a time scale of
microseconds, with low pH favoring the inverted V and
L-shaped conformations (42). We observe that WT peptide
is unique in its ability to fill space in the vesicle outer leaflet
(Fig. 4 A), order the bilayer interior (Fig. 4 C), and to limit
water penetration (Fig. 4 B). These observations suggest
that WT contributes a positive ‘‘intrinsic curvature’’ to
reduce outer leaflet curvature stress in SUVs.
All the mutants are structurally distinct from WT. G1S
has an N-terminal Ser but is reported to have a structure
and kink angle on a membrane similar to the WT (18),
even though our measurements of bilayer properties argue
that its structure on the membrane should be significantly
different from that of WT. We observed that G1S, because
the N-terminal serine will be enthalpically drawn to the
more polar bilayer interface, excludes water even more
effectively than WTat low temperature (Fig. 4 B) and orders
the interface especially at low temperature (Fig. 4 D). We
hypothesize that its conformational ensemble favors the pre-
viously reported hairpin conformation (41) at low tempera-
tures but likely broadens as temperature increases to include
‘‘inverted V’’ conformations. Based on these observations,
G1S may relieve outer leaflet curvature stress at low temper-
atures but may aggravate it at higher temperatures.
The W14A mutant peptide is reported to have a ‘‘kink
angle’’ that is ill defined relative to WT (17). Consistent
with this, W14A uniquely switched from slightly producing
free volume to dramatically limiting it at high temperature
(Fig. 4 A). Similarly, its influence on the interface uniquely
switched from ordering at low temperature to disordering at
high temperature (Fig. 4 D). Unlike W14A, G1V is pro-
posed to form a rigid helix from G4 toW14 (18), but, similar
to W14A, its ability to permit water penetration (Fig. 4 B)
and leakage from SUVs (Table 1) also increased dramati-
cally with temperature. However, it was also notably more
effective at disordering the interface at high temperaturesBiophysical Journal 105(11) 2495–2506than was W14A (Fig. 4 D). Thus, although they do fill upper
bilayer space with increasing temperature, they likely do so
by abandoning and disrupting the interface (Fig. 4 D), thus
permitting increasing water penetration and leakage (Table
1). These observations are consistent with both peptides
increasing, rather than decreasing, outer leaflet positive cur-
vature stress, i.e., contributing a negative intrinsic curvature
to cis leaflets, with G1V likely having the greater effect.
To summarize, although all four of these peptides are
distinct, the mutant peptides seem to lack the WT peptide’s
ability to contribute a positive ‘‘intrinsic curvature’’ to
reduce outer leaflet curvature stress in SUVs or to order
acyl chains.Peptide influences on activation thermodynamics
and bilayer structure provide hypotheses for
mechanisms of catalysis or inhibition
The activation thermodynamics of the three steps in the
fusion process for control vesicles have been published
(30) and support structural models for transition states of
each step of PEG-mediated fusion: Step 1—chain protrusion
into dehydrated space between closely apposed vesicles;
Step 2—continuous evolution of structures with a single
topology whose energies can be estimated from bulk lipid
material properties (see (24)); and Step 3—correlated
rearrangements of two or more lipids at stressed edges of
single-bilayer intervesicle diaphragms (TMC (Trans-mem-
brane contact) or ETMC geometries in Fig. S3) to reduce
both negative curvature stress and interstice stress (30).
We now propose that the effects of WTand mutant HA pep-
tides on activation thermodynamics and on bilayer proper-
ties can support hypotheses for how these peptides might
alter the microstructural ensembles constituting the interme-
diates and transition states of the fusion process. In doing so,
we rely on our knowledge of the bilayer state of the SUV
model system as well as on a calculation of the energetics
of the free-energy-minimized semistable intermediates in
the fusion process (24).First step: Initial intermediate formation
The activation free energies for each step of the fusion pro-
cess result from large entropic and enthalpic contributions
leading to a relatively small activation free energy (en-
tropy/enthalpy compensation) (30). Thus, each step is said
to be enthalpically ðDH1%TDS1<<0Þ or entropically
allowed ðTDS1RDH1>>0Þ. We will refer to the catalytic
influence of fusion peptides in similar terms: entropic
catalysis ðTDDS1RDDH1>0Þ versus enthalpic catalysis
ðDDH1%TDDS1<0Þ. Step 1 of the fusion process for
PEG-mediated SUV fusion is entropically allowed (30).
The activation thermodynamics of Step 1 were proposed
to reflect a transition state (TS1 in Fig. S3) involving expo-
sure and movement of lipid acyl chain into the dehydrated
Effects of HA Fusion Peptides on Bilayer Structure, Fusion Kinetics, and Activation Thermodynamics 2503interbilayer space between contacting cis leaflets (30). This
proposal is in line with a coarse grain simulation of stalk for-
mation between flat bilayers at low hydration and high tem-
perature (43) and with an all atom MD simulation of highly
curved bilayers in close contact (44), a system somewhat
akin to our experimental system. We address the influence
of WT HA and mutant fusion peptides on Step 1 in the
context of this proposal.
Only WT peptide enthalpically catalyzed Step 1 over the
entire temperature range (Fig. 3 B). WT peptide was distin-
guished by its ability to fill free volume and to order bilayer
acyl chains (Fig. 4, A and C). This should allow it to fill the
hydrophobic voids left by acyl chain movement into interbi-
layer space in TS1 and reduce the enthalpic cost of water
entering this space ðDDH1<0Þ. It will also reduce the
entropic gain of removing water from the highly ordered
interbilayer space (45) ðTDDS1<0Þ. A change of DDCp1
from positive to negative with temperature (Fig. S4) is
consistent with WT peptide promoting acyl chain protru-
sion that breaks very rigid water structure in the interbi-
layer space (45) and replaces it with hydrophobic
hydration of acyl chains. At higher temperatures, the effect
of fewer and increasingly enthalpically favorable states
ðDH1%TDS1<<0Þ outweighs the hydrophobic effect and
DDCp1 becomes negative. This proposal for the catalytic
role of WT peptide on Step 1 is consistent with the predic-
tions of a very recent all-atom simulation that predicts that
WT peptide should increase the probability of acyl chain
protrusions (46).
In summary, our structural and activation thermodynamic
observations suggest that WT peptide catalyzes Step1 by
filling hydrophobic voids left in TS1 monolayers because
of acyl chain protrusion. This contrasts with previous sug-
gestions that WT fusion peptides favor fusion by altering
the initial state A (19,20).
A detailed discussion of the roles of mutant peptides in
catalyzing Step 1 is given in the Supporting Material.
Briefly: 1) G1S’s conformational ensemble makes it
ineffective in compensation for acyl chain protrusion but
capable of disrupting ordered water in the interbilayer
space at low temperature, whereas its apparent ability to
contribute a negative intrinsic curvature to exposed SUV
leaflets destabilizes state A at high temperatures. 2) Both
the G1V and W14A peptides appear to possess broad, tem-
perature-dependent conformational ensembles that destabi-
lize state A by contributing a negative intrinsic curvature
to exposed leaflets, but also by entropically stabilizing
TS1 by increasing the number of microstructures contrib-
uting to it, perhaps by partially entering the interbilayer
space.Second step
The time courses obtained with WT peptide were well
described by a model involving only one intermediate. Asingle intermediate reaction in the presence of WT peptide
indicates that either I2 could be destabilized i.e., (I2 free
energy is approximately that of TS2), allowing I1 to proceed
directly to TS3 without passing through a semistable I2
intermediate; or I1 could evolve without any significant
barrier to I2 (i.e., TS2 free energy lowered), which would
then proceed via TS3 to FP. For the sake of consistency
with results obtained in the absence of fusion peptide, we
maintain the nomenclature that k3 is the rate of pore
formation and DG3* the transition state energy for pore
formation. As noted, however, it is uncertain at this
point whether k3 in the presence of WT peptide is the rate
of I1/ FP or I2/ FP.
In the absence of fusion peptides,DH2*TTDS2*> 0, and
DCp2* < 0 (30), consistent with the increase in positive
bending stress and the decrease in interstice energy at the
trans-membrane contact (TMC) geometry that roughly de-
fines TS2 (Fig. S3) (24,30). As for Step 1, a detailed discus-
sion of mutant peptides’ influences on Step 2 is reserved to
the Supporting Material to save space. The limited catalytic
influence of G1S on Step 2 appears to reflect its ability to
impart slight intrinsic negative curvature to the exposed cis
leaflet of TS2, thereby lowering its free energy (TMC
geometry in Fig. S3). The catalytic effect of W14A appears
to derive from its ability to contribute a negative intrinsic
curvature to the exposed monolayer. Finally, the catalytic in-
fluence ofG1Vis proposed to reflect both a substantial ability
to impart both a negative intrinsic curvature to the exposed
leaflet in TS2 and to reduce interstice energy in this transition
state. These effects of G1V not only should lower the free
energy of TS2 but also should allow it to dramatically stabi-
lize I2, thus blocking FP formation (see Step 3).Third step: WT peptide influence on final pore
formation
The stalk must expand to or beyond the TMC structure to
transform into a fusion pore (24). Any hemi-fused structure
that proceeds beyond the TMC structure has ‘‘extended
trans-membrane contact’’ (ETMC) geometry (Fig. S3) and
has stressed cis and trans leaflets at its circumference.
Both the I2 and the TS3 ensembles have ETMC geometries;
the only difference being their different average stalk radii:
r2 for I2 and rS*, where rS*is a critical stalk radius beyond
which TS3 is unlikely to persist and a final fusion pore is
very likely (30). In the absence of WT peptide, rS* is greater
than r2, and the system must pass through I2 to reach rS*.
Fig. S3 illustrates that the TMC and ETMC cross-sections
have enormous negative curvature stress in both cis and
trans leaflets at the periphery of their single bilayer dia-
phragms. Expansion of the ETMC diaphragm increases total
cis leaflet negative curvature stress, thereby relieving the
unfavorable positive curvature stress of SUV outer leaflets.
This produces a driving force for stalk radius expansion
(24). Opposing this is unfavorable interstice energyBiophysical Journal 105(11) 2495–2506
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the nonlamellar ETMC circumference (24). The larger the
stalk radius, the larger the ETMC circumference and thus
the greater the total negative curvature stress and unfavor-
able interstice energy. Our hypothesis for pore formation
(30) is that both curvature stress and interstice energy at
the ETMC circumference can be relieved by coordinated
movement of lipids from stressed cis and trans leaflets
(Fig. S3) into interstices to create a local, pore-like fluctua-
tion. The presence of such microstructures in the intermedi-
ate state ensemble can account for the probabilities ai, but at
rS*, become so numerous or unstable that a final pore (FP
state) forms (30).
Our membrane structure measurements show that
WT peptide was almost unique in contributing a positive
‘‘intrinsic curvature’’ to the cismonolayer and reducing pos-
itive curvature stress in the SUVouter leaflet. This contrasts
with the proposal that WT peptide has a negative intrinsic
curvature, which is based on the observation that both phos-
phatidylethanolamine (with a known intrinsic negative cur-
vature) and WT peptide promote hexagonal phase formation
(47). However, fusion peptides also decrease bending
modulus, which would also lower the free energy barrier
to a hexagonal phase (21). Thus, the observation that WT
peptide promotes hexagonal phase formation need not
imply that it has a negative intrinsic curvature. In support
of WT peptide imparting a positive intrinsic curvature to
stressed cis leaflets is the observation that it favors highly
curved cubic phases that require reduced negative Gaussian
curvature more than do mutant peptides (22). We thus
submit that an important effect of the WT peptide should
be its ability to provide a positive intrinsic curvature to
the cis leaflet of fusion intermediates.
The ability of WT peptide to impart a positive intrinsic
curvature to exposed cis leaflets can explain the disappear-
ance of the I2 state in the presence of WT peptide (Tables 1
and S3). Small increases in positive intrinsic curvature
dramatically increase the barrier to I2 formation and desta-
bilize I2 (24). This appears inconsistent with the aforemen-
tioned possibility that I1 decays spontaneously to I2, but it is
consistent with the possibility that an evolving ETMC
geometry bypasses an unstable I2 to directly reach the rS*
in TS3. The fact that k2 at 26
C T k3 at 30C means that
the free energy barrier to reach rS* directly from I1 is appar-
ently still quite large, and rS* may still be larger than r2.
However, it could also be the positive intrinsic curvature
of WT peptide so destabilizes the ETMC circumference
that the frequency or size of pore-like microstructural
fluctuations becomes sufficient that rS* moves to stalk
radii comparable with that of I2, i.e., the I2 state would never
be reached. We cannot distinguish between these possibil-
ities, but in both cases the ability of WT peptide to impart
a positive intrinsic curvature to exposed cis leaflets is
consistent with the loss of the second intermediate and
promotion of pore formation. This hypothesis is supportedBiophysical Journal 105(11) 2495–2506by the ability of hexadecane to restore I2 (Tables 1
and S4) in that the decrease in interstice energy because
of hexadecane addition will stabilize I2 and lower the TS2
(TMC) barrier (24).
Work of some researchers has proposed that fusion occurs
directly from an unstable ‘‘stalk’’ structure (48), a proposal
apparently at odds with our hypothesis for pore formation
from an ETMC or at least a TMC geometry. A field theoret-
ical extension of this work using simplified coarse potentials
further predicted that the highly stressed edges of stalks
stabilize pores form ‘‘stalk-pore complexes’’ (26), but the
dimensions of the ‘‘stalk’’ at these complexes are roughly
as we would identify for a TMC or ETMC structure (24).
Another coarse-grained treatment that included HA fusion
peptides predicted what was described as a bicontinuous
(interlocking water and hydrophobic regions) ‘‘diamond
phase’’ (adjacent pores and stalks) that was stabilized by
WT but not mutant peptides (25). Again the dimensions of
this peptide-promoted stalk was ~4 nm, roughly what we
would identify as an ETMC (24). Thus, what these authors
call ‘‘stalks’’ could well be TMC or ETMC structures by our
definition. In addition, what they call ‘‘stalk-pore com-
plexes’’ are consistent with our view that evolution of I1
toward FP proceeds through an ETMC or minimally
a TMC geometry, with pore formation because of correlated
lipid movements at the strained peripheries of these
structures (37).
As for Steps 1 and 2, a discussion of proposed mecha-
nisms for mutant peptides’ inhibition of Step 3 is provided
in the Supporting Material. G1V has the greatest ability to
contribute intrinsic negative curvature to the merged cis
leaflets, promotes ETMC expansion, and lowers the free en-
ergy of I2 (37). Thus, we propose that G1V blocks FP state
formation by stabilizing I2 and decreasing the driving force
(reducing positive cis leaflet curvature stress) for reaching a
stalk radius of rS*. Consistent with this, hexadecane restores
FP formation in the presence of G1V peptide (Table S4) and
appears to promote ETMC expansion and destabilize I2 suf-
ficiently to overcome the influence of G1V’s negative curva-
ture (24). W14A also contributes intrinsic negative
curvature to the merged cis leaflets and inhibits pore forma-
tion by stabilizing I2.
The G1S mutant was proposed to impart slight negative
intrinsic curvature at high temperature and thus inhibit
pore formation in a similar way. At low temperature, it
does not fill space (Fig. 5 A) and is unable to promote
ETMC expansion by filling interstice space and subse-
quently inhibit fusion. For mutants, we are led to believe
that the introduction of a more negative intrinsic curvature
(mainly enthalpic in nature) has a greater influence than
the ability to reduce interstice energy (mainly entropic).
These two competing influences also likely account the
observed DDH3 > TDDS

3 > 0 for mutant peptides. Detailed
discussion on the effect of mutant peptides on the pore for-
mation is in the Supporting Material.
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We had previously hypothesized that WT HA peptide pro-
motes fusion by occupying hydrophobic space and reducing
interstice energy (13,49), although we could not comment
until recently on the step(s) at which this influence might
occur (15). A more careful examination of kinetics over a
temperature range, as presented in this study, discounts
this proposal (Tables 1 and S4 and Fig. 5). Fig. 5 A shows
that the effects of hexadecane and WT peptide on Step 1
diverge enormously as temperature increases, and even
significantly oppose each other. Based on our observations
and the discussion so far, we propose that these two agents
catalyze Step 1 by different mechanisms, especially at high
temperatures: 1) WT peptide specifically orders the bilayer
interior and thereby promotes acyl chain excursions into the
interbilayer space, whereas 2) hexadecane can align with
acyl chains at low temperatures but at high temperatures,
it can only occupy hydrophobic free volume and reduce in-
terstice energy (30). This explains why its catalytic ability
alone or in the presence of WT peptide is so temperature
dependent (Fig. 5 A). The fact that hexadecane increasingly
inhibited the catalytic influence of WT peptide on Step 1
with increasing temperature (Fig. 5 A) supports the conclu-
sion that the catalytic mechanism by which WT peptide op-
erates is not primarily because of reducing interstice energy.
The differing influences of WT fusion peptide and hexa-
decane on Step 2 further argue that WT peptide does not
promote fusion by the interstice-filling mechanism of hexa-
decane. Although WT peptide eliminated Step 2 because of
its positive contribution to cis leaflet curvature, hexadecane
increased k2 at higher temperatures (Fig. 5 B) because of its
interstice-filling ability.
The effects of hexadecane and WT peptide appear to be
more similar for Step 3 in that both WT peptide and hexade-
cane decrease DG3 with similar temperature dependencies
(Fig. 5 C) and catalyze Step 3 in an entropic fashion (Figs.
3 F and 5 F). However, the catalytic influence of WT peptide
on Step 3 was largely reversed by addition of hexadecane, as
was the effect of hexadecane reversed by addition ofWTpep-
tide (Fig. 5 C). Again, this is consistent with the prediction
that increased positive intrinsic curvature and decreased in-
terstice energy have opposing influences (24).
We conclude that WT peptide does not catalyze any step
of the fusion process in a manner similar to that of hexade-
cane, thereby discounting the hypothesis that WT peptide
operates only (or even significantly) by filling space and
lowering interstice energy (13,49).SUPPORTING MATERIAL
Materials, methods, description of the model, discussion on mutant pep-
tides, four figures and four tables are available at http://www.biophysj.
org/biophysj/supplemental/S0006-3495(13)01138-7.
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